GR1003490B - Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης - Google Patents

Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης

Info

Publication number
GR1003490B
GR1003490B GR990100418A GR990100418A GR1003490B GR 1003490 B GR1003490 B GR 1003490B GR 990100418 A GR990100418 A GR 990100418A GR 990100418 A GR990100418 A GR 990100418A GR 1003490 B GR1003490 B GR 1003490B
Authority
GR
Greece
Prior art keywords
paraxetine
salt
pharmaceutical compositions
novel pharmaceutical
novel
Prior art date
Application number
GR990100418A
Other languages
English (en)
Inventor
David Philip Dr. Elder
Padma Meneaud
Ahmad Khalaf Al Deeb A Ghazani
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of GR1003490B publication Critical patent/GR1003490B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Μια νέα σύνθεση η οποία περιλαμβάνει άλας μεθανοσουλφουρικού εστέρος παροξετίνης η οποία σχηματίζεται με ένα υδροδιαλυτό ή υδρόφιλο διαλύτη και η χρήση της στη θεραπεία ή την αποτροπή νοητικών δυσλειτουργιών.ΰ
GR990100418A 1999-06-22 1999-12-03 Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης GR1003490B (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (1)

Publication Number Publication Date
GR1003490B true GR1003490B (el) 2000-11-30

Family

ID=27269749

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990100418A GR1003490B (el) 1999-06-22 1999-12-03 Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης

Country Status (21)

Country Link
EP (1) EP1064936A1 (el)
AT (1) AT3722U1 (el)
AU (2) AU1573100A (el)
BE (2) BE1012806A3 (el)
CA (1) CA2291542A1 (el)
CH (1) CH690024A5 (el)
DE (2) DE19958228A1 (el)
DK (2) DK199900435U3 (el)
ES (1) ES2159260B1 (el)
FI (2) FI19992609A7 (el)
FR (1) FR2795327A1 (el)
GB (1) GB2351233A (el)
GR (1) GR1003490B (el)
IE (2) IES991108A2 (el)
IT (1) ITMI992549A1 (el)
LU (1) LU90483B1 (el)
NL (2) NL1013750C1 (el)
NO (1) NO995945L (el)
PT (1) PT102384A (el)
SE (1) SE9904404L (el)
WO (1) WO2000078291A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2418038A1 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same
AU2001284322A1 (en) 2000-08-29 2002-03-13 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (en) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquid for oral administration comprising paroxetine
MXPA04007428A (es) 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371092A (en) * 1990-11-24 1994-12-06 Beecham Group, P.L.C. Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
WO1997003670A1 (en) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Paroxetine controlled release compositions
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
EP0970955A1 (en) * 1998-07-02 2000-01-12 Smithkline Beecham Plc Paroxetine methanesulfonate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371092A (en) * 1990-11-24 1994-12-06 Beecham Group, P.L.C. Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
WO1997003670A1 (en) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Paroxetine controlled release compositions
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
EP0970955A1 (en) * 1998-07-02 2000-01-12 Smithkline Beecham Plc Paroxetine methanesulfonate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUCKER H. ET AL: "Pharmazeutische Technologie", 1991, THIEME VERLAG, STUTTGART, XP002141179, 189560 *

Also Published As

Publication number Publication date
NO995945D0 (no) 1999-12-03
FI4488U1 (fi) 2000-07-20
CH690024A5 (fr) 2000-03-31
FI19992609L (fi) 2000-12-22
NL1013750C1 (nl) 2000-12-28
FI19992609A7 (fi) 2000-12-22
ITMI992549A1 (it) 2001-06-03
AU1573100A (en) 2001-01-09
SE9904404L (sv) 2000-12-23
WO2000078291A1 (en) 2000-12-28
DE29921300U1 (de) 2000-02-10
LU90483B1 (fr) 2001-01-31
ES2159260A1 (es) 2001-09-16
IE991107A1 (en) 2001-05-30
BE1012806A3 (fr) 2001-03-06
NL1013749C2 (nl) 2001-01-08
EP1064936A1 (en) 2001-01-03
CA2291542A1 (en) 2000-12-22
SE9904404D0 (sv) 1999-12-03
GB9928673D0 (en) 2000-02-02
PT102384A (pt) 2000-12-29
AT3722U1 (de) 2000-07-25
FR2795327A1 (fr) 2000-12-29
GB2351233A (en) 2000-12-27
ES2159260B1 (es) 2002-05-01
DE19958228A1 (de) 2000-12-28
DK199901730A (da) 2000-12-23
FIU990494U0 (fi) 1999-12-03
AU727000B3 (en) 2000-11-30
IES991108A2 (en) 2001-04-04
DK199900435U3 (da) 2000-02-11
ITMI992549A0 (it) 1999-12-03
NO995945L (no) 2000-12-27
BE1013166A6 (fr) 2001-10-02

Similar Documents

Publication Publication Date Title
CY2013032I2 (el) Συζυγη της εξενδινης-4 και η φαρμακευτικη τους χρηση
BR0313747A (pt) Inibidores de transcriptase reversa de não-nucleosìdeo
BR0011433A (pt) Imidazoquinolinas substituìdas com sulfonamida e sulfamida
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
CY1110954T1 (el) Ημιστερεες βλεννοκολλωδεις φαρμακοτεχνικες μορφες
CY1114420T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη για την αγωγη της ψωριασης
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
EA200200922A1 (ru) Композиция, включающая камптотецин и производное пиримидина, для лечения рака
IT1305313B1 (it) 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
ATE410148T1 (de) Pharmazeutische zubereitung zur oralen verwendung von heparin und seinen derivaten
BR0014372A (pt) Derivados de 5-hidroxissapogenina com atividade antidemência
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
EE05211B1 (et) Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
FR2846327B1 (fr) Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
SE0001916D0 (sv) Novel formulation
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees